Objective: To analyze the impact of Body Mass Index (BMI) on clinical and patient-reported outcomes following gender-affirming mastectomy (GM). Background: BMI is a barrier for obese patients seeking GM despite increasing evidence that it is safe in this population. Currently, little is known about the impact of BMI on chest-specific body image and satisfaction after GM. Methods: This single-center, cross-sectional study included individuals 18 years and older who underwent GM between 1990 and 2020 and were at least 2 years postoperative. Patient-reported chest-specific body image was measured using the BODY-Q and Gender Congruence and Life Satisfaction chest subscales. Satisfaction was measured using the Holmes-Rovner Satisfaction with Decision scale. Clinical and demographic variables were identified from the chart review. Bivariate analysis was performed to determine whether BMI was associated with chest-specific body image, satisfaction, and complications within 30 days or revisions in GM. Results: Two hundred twenty-seven individuals meeting eligibility criteria were contacted to participate and 137 responded (60.4% response rate). The mean age was 29.1 (SD=9.0), and mean BMI was 30.9 (SD=8.0), with 26.4% (N=60) of the cohort having a BMI>35. Chest-specific body image and satisfaction with the decision did not vary by BMI or breast resection weight. Complications and revisions were not associated with BMI. Conclusions: Individuals undergoing GM reported high rates of satisfaction after GM regardless of BMI. Complication and revision rates did not vary significantly by BMI or breast resection weight. Surgeons should re-evaluate the role BMI plays in patient selection and counseling for GM.
Transgender and gender-diverse (TGD) patients face multifactorial barriers to accessing medically-necessary interventions, including gender-affirming chest surgery (GACS). Surgeons may exacerbate this inequity by imposing preoperative body mass index (BMI) requirements on their patients. Recent studies present conflicting evidence regarding the association between BMI and postoperative complications following GACS; however, no studies have assessed these outcomes in cases of extremely high BMI (>40 kg/m2). Assigned female at birth patients ≥ 18 years old undergoing GACS at three institutions were reviewed. Demographic and clinical characteristics were analyzed descriptively between patients with BMI ≤40 and >40 kg/m2. A multivariable logistic model was used to determine the effect of BMI on complications. 647 patients were included, of these, 82 (12.7%) had BMI >40 kg/m2. Among patients with BMI >40 kg/m2, 21.9% had at least one complication. A significant association was observed between BMI and overall complications (p=0.0026). Adjusted analyses suggested that patients with BMI >40 kg/m2 were 2.34 times more likely to experience at least one complication (95% CI 1.153, 4.733). Overall complications, incisional dehiscence, and major complications (requiring unplanned readmission and/or reoperation) were significantly higher in patients with BMI >40 kg/m2. This multi-institutional retrospective review demonstrates a higher frequency of adverse outcomes in patients with BMI >40 kg/m2. GACS can be performed safely in patients with extreme BMI, however appropriate informed consent is necessary. These data will facilitate evidence-based counseling on the risks and benefits of GACS in this patient population.